Gene editing technology to improve antitumor T-cell functions in adoptive immunotherapy
Abstract Adoptive immunotherapy, in which tumor-reactive T cells are prepared in vitro for adoptive transfer to the patient, can induce an objective clinical response in specific types of cancer. In particular, chimeric antigen receptor (CAR)-redirected T-cell therapy has shown robust responses in h...
Saved in:
Main Authors: | Yusuke Ito (Author), Satoshi Inoue (Author), Yuki Kagoya (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fine and Predictable Tuning of TALEN Gene Editing Targeting for Improved T Cell Adoptive Immunotherapy
by: Anne-Sophie Gautron, et al.
Published: (2017) -
Intestinal microbiota and related metabolites are essential mediators for adoptive γδT cell antitumor immunotherapy
by: Jiajia Han, et al.
Published: (2022) -
Adoptive Immunotherapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors
by: Hiroshi Fujiwara
Published: (2014) -
NKT Cells in Cancer Immunotherapy, 2nd Edition
Published: (2020) -
Nanotechnology in cervical cancer immunotherapy: Therapeutic vaccines and adoptive cell therapy
by: Xuyan Zhou, et al.
Published: (2022)